Skip Nav Destination
Issues
15 November 2011
-
Cover Image
Cover Image
Pretreating mice with chemotherapy can enhance metastasis formation in the lungs of mice. Daenen and colleagues and Gingis-Velitski and colleagues report that chemotherapy has effects on the microenvironment that account for these protumorigenic effects. Expression of vascular endothelial growth factor receptor 1 (VEGFR-1) is enhanced on a subset of endothelial cells in the lungs of mice following chemotherapy exposure. On the cover, mouse lung endothelial cells after cisplatin pretreatment are shown, characterized by CD31 expression (red) and VEGFR-1 expression (green). Knowledge of the host effects induced by chemotherapy may facilitate strategies to improve therapy efficacy. For details, see the article by Daenen and colleagues on page 6976 and the article by Gingis-Velitski and colleagues on page 6986 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Meeting Report
Priority Reports
Integrated Systems and Technologies
Microenvironment and Immunology
Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
Michelle Hong; Anne-Laure Puaux; Caleb Huang; Laure Loumagne; Charlene Tow; Charles Mackay; Masashi Kato; Armelle Prévost-Blondel; Marie-Françoise Avril; Alessandra Nardin; Jean-Pierre Abastado
Molecular and Cellular Pathobiology
Therapeutics, Targets, and Chemical Biology
Tumor and Stem Cell Biology
AGR2 Is a Novel Surface Antigen That Promotes the Dissemination of Pancreatic Cancer Cells through Regulation of Cathepsins B and D
Laurent Dumartin; Hannah J. Whiteman; Mark E. Weeks; Deepak Hariharan; Branko Dmitrovic; Christine A. Iacobuzio-Donahue; Teresa A. Brentnall; Mary P. Bronner; Roger M. Feakins; John F. Timms; Caroline Brennan; Nicholas R. Lemoine; Tatjana Crnogorac-Jurcevic
Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
Vyomesh Patel; Christina A. Marsh; Robert T. Dorsam; Constantinos M. Mikelis; Andrius Masedunskas; Panomwat Amornphimoltham; Cherie Ann Nathan; Bhuvanesh Singh; Roberto Weigert; Alfredo A. Molinolo; J. Silvio Gutkind
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.